Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control-Reference-Cited by-同舟云学术

Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control

Author:

Dambska M¹,Labrador EB¹,Kuo CL²³,Weinstein DA¹⁴^ORCID

Affiliation:

1. Glycogen Storage Disease Program; Connecticut Children's Medical Center; Hartford Connecticut

2. Department of Community Medicine and Health Care; University of Connecticut School of Medicine; Farmington Connecticut

3. Connecticut Institute for Clinical and Translational Science; Farmington Connecticut

4. Department of Pediatrics; University of Connecticut School of Medicine; Farmington Connecticut

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine

Link

Reference44 articles.

3. Hepato-nephro-megalia-glycogenica (Glykogenspeicherkrankheit der Leber und Nieren);Gierke;Beitr Pathol Anat,1929

4. Glucose-6-phosphatase of the liver in glycogen storage disease;Cori;J Biol Chem,1952

5. The effect of portacaval transposition on carbohydrate metabolism: experimental and clinical observations;Starzl;Surgery,1965

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献